ABBOTT INDIA
|
The Current P/E Ratio of ABBOTT INDIA is 48.01.
Share Price | ₹25,945.6 | May 08,2024 |
Market Cap | ₹55,004.7 Cr | |
Earnings-TTM | ₹1,145.6 Cr | TTM-Standalone Results |
Price/Earnings | 48.01x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of ABBOTT INDIA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹55,004.7 Cr] as on May 08,2024
(/) Earnings [ ₹1,145.6 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 48.01x ]
Thus, for ABBOTT INDIA , the investors are currently willing to pay 48.01 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ABBOTT INDIA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ABBOTT INDIA over the last five years.
Historical PE (Price/Earnings) ratio chart of ABBOTT INDIA
PE Ratio Performance Analysis for ABBOTT INDIA
- ABBOTT INDIA 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 46.49x.
- ABBOTT INDIA 's operated at median p/e ratio of 47.09x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ABBOTT INDIA 's p/e ratio peaked in Mar2020 at 55.39x.
- ABBOTT INDIA 's p/e ratio hit its five-year low in Mar2019 of 34.43x.
How does ABBOTT INDIA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
ABBOTT INDIA | 1,145.58 | 48.01 | 55,004.7 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 8,998.63 | 40.57 | 365,071.0 |
CIPLA LTD | 3,744.03 | 29.86 | 111,808.0 |
DR REDDYS LABORATORIES LTD | 5,563.20 | 18.16 | 101,035.0 |
ZYDUS LIFESCIENCES LTD | 2,954.20 | 34.26 | 101,202.0 |
DIVIS LABORATORIES LTD | 1,382.97 | 75.42 | 104,300.0 |
MANKIND PHARMA LTD | 1,743.30 | 50.09 | 87,328.3 |
TORRENT PHARMACEUTICALS LTD | 1,494.00 | 58.62 | 87,582.9 |
LUPIN LTD | 1,935.57 | 38.05 | 73,640.1 |
AUROBINDO PHARMA LTD | 2,777.89 | 23.96 | 66,562.6 |
ALKEM LABORATORIES LTD | 1,574.66 | 39.24 | 61,797.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ABBOTT INDIA 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.16x |
Max industry PE | 75.42x |
Median industry PE | 39.24x |
Average industry PE | 41.48x |
You may also like the below Video Courses